In our study, we first established a link between ubiquitination modification and CML-LSCs based on multiple ubiquitination modification-related genes, in which UHRF1 and CDC20 were identified as the novel potential target genes as well as FANCD2 previously well investigated in CML. The gene discussed is FANCD2; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.